Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1941 Mar 31;73(4):493–506. doi: 10.1084/jem.73.4.493

THE EFFECT OF A POLYSACCHARIDE-SPLITTING ENZYME ON STREPTOCOCCAL INFECTION

George K Hirst 1
PMCID: PMC2135142  PMID: 19871093

Abstract

1. Confirming the observations of other experimenters, it has been found that group A hemolytic streptococci produce a capsule containing a polysaccharide which is similar to, if not identical with, certain high molecular weight sugars found in the mammalian body. 2. Leech extract possesses a powerful enzyme capable of splitting one of the linkages in this polysaccharide and of decapsulating group A and group C hemolytic streptococci in vitro and in vivo. 3. Mice and guinea pigs can be protected from intraperitoneal infection with a virulent group C streptococcus by the intraperitoneal administration of leech extract. In contrast there is little protective action of leech extract in mice infected with group A hemolytic streptococci. 4. The protective effect of leech extract against streptococcal group C infection is probably due to the removal of the capsule in vivo. 5. The capsule of mouse virulent group C streptococci plays a major rôle in the virulence of that microorganism, while the capsule of certain mouse virulent group A streptococci plays little, if any, rôle in virulence, at least when the infection is intraperitoneal in the mouse.

Full Text

The Full Text of this article is available as a PDF (817.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Claude A. SPREADING PROPERTIES OF LEECH EXTRACTS AND THE FORMATION OF LYMPH. J Exp Med. 1937 Aug 31;66(3):353–366. doi: 10.1084/jem.66.3.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Goebel W. F. THE ISOLATION OF THE BLOOD GROUP A SPECIFIC SUBSTANCE FROM COMMERCIAL PEPTONE. J Exp Med. 1938 Jul 31;68(2):221–227. doi: 10.1084/jem.68.2.221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hirst G. K., Lancefield R. C. ANTIGENIC PROPERTIES OF THE TYPE-SPECIFIC SUBSTANCE DERIVED FROM GROUP A HEMOLYTIC STREPTOCOCCI. J Exp Med. 1939 Feb 28;69(3):425–445. doi: 10.1084/jem.69.3.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Lancefield R. C. THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HAEMOLYTICUS : II. CHEMICAL AND IMMUNOLOGICAL PROPERTIES OF THE PROTEIN FRACTIONS. J Exp Med. 1928 Feb 29;47(3):469–480. doi: 10.1084/jem.47.3.469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Meyer K., Hobby G. L., Chaffee E., Dawson M. H. THE HYDROLYSIS OF HYALURONIC ACID BY BACTERIAL ENZYMES. J Exp Med. 1940 Jan 31;71(2):137–146. doi: 10.1084/jem.71.2.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Seastone C. V. Capsules in Young Cultures of Streptococcus hemolyticus. J Bacteriol. 1934 Nov;28(5):481–487. doi: 10.1128/jb.28.5.481-487.1934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Seastone C. V. THE VIRULENCE OF GROUP C HEMOLYTIC STREPTOCOCCI OF ANIMAL ORIGIN. J Exp Med. 1939 Sep 30;70(4):361–378. doi: 10.1084/jem.70.4.361. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES